SFG
LLY icon

SNS Financial Group’s Eli Lilly LLY Stock Holding History

SNS Financial Group’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.42M Buy
1,546
+21
+1% +$21.3K 0.12% 70
2025
Q4 		$1.64M Buy
1,525
+101
+7% +$96.6K 0.14% 63
2025
Q3 		$1.09M Buy
1,424
+6
+0.4% +$4.46K 0.09% 83
2025
Q2 		$1.11M Buy
1,418
+41
+3% +$31.9K 0.11% 78
2025
Q1 		$1.14M Buy
1,377
+778
+130% +$647K 0.12% 76
2024
Q4 		$463K Sell
599
-21
-3% -$17.4K 0.05% 116
2024
Q3 		$549K Sell
620
-5
-0.8% -$4.5K 0.06% 112
2024
Q2 		$566K Buy
625
+133
+27% +$106K 0.06% 109
2024
Q1 		$383K Hold
492
– – 0.04% 130
2023
Q4 		$287K Buy
492
+27
+6% +$15.8K 0.03% 148
2023
Q3 		$250K Buy
+465
New +$240K 0.03% 154
2022
Q1 		– Sell
-8,416
Closed -$2.33M – 241
2021
Q4 		$2.33M Buy
8,416
+8
+0.1% +$2.03K 0.25% 60
2021
Q3 		$1.94M Buy
8,408
+94
+1% +$23.2K 0.23% 62
2021
Q2 		$1.91M Sell
8,314
-376
-4% -$75.5K 0.24% 59
2021
Q1 		$1.62M Sell
8,690
-386
-4% -$75.5K 0.22% 69
2020
Q4 		$1.53M Sell
9,076
-2,022
-18% -$302K 0.22% 65
2020
Q3 		$1.64M Sell
11,098
-391
-3% -$60.5K 0.26% 54
2020
Q2 		$1.89M Sell
11,489
-520
-4% -$79.8K 0.34% 48
2020
Q1 		$1.67M Sell
12,009
-916
-7% -$126K 0.32% 57
2019
Q4 		$1.7M Buy
12,925
+1,218
+10% +$141K 0.3% 56
2019
Q3 		$1.31M Sell
11,707
-391
-3% -$43.5K 0.25% 65
2019
Q2 		$1.34M Sell
12,098
-568
-4% -$66.9K 0.25% 66
2019
Q1 		$1.64M Sell
12,666
-216
-2% -$26.3K 0.36% 50
2018
Q4 		$1.49M Buy
+12,882
New +$1.44M 0.37% 54
2015
Q4 		– Sell
-6,367
Closed -$533K – 131
2015
Q3 		$533K Buy
6,367
+200
+3% +$16.9K 0.15% 79
2015
Q2 		$515K Buy
+6,167
New +$470K 0.16% 76

Other funds holding LLY

Lilly Endowment
Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

SNS Financial Group's LLY Position: Q1 2026 in Review

SNS Financial Group increased its Eli Lilly (LLY) stake by 1.4% in Q1 2026, buying an estimated $21.3K and bringing the position to 1,546 shares worth $1.42M. The position accounts for 0.12% of the portfolio, ranked #70.

SNS Financial Group first reported a position in LLY in Q2 2015 and has held it in 26 quarters since. The position peaked at $2.33M in Q4 2021. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • SNS Financial Group held 1,546 shares of Eli Lilly worth $1.42M as of Q1 2026.
  • SNS Financial Group bought 21 Eli Lilly shares in Q1 2026, an estimated $21.3K.
  • Eli Lilly made up 0.12% of SNS Financial Group's portfolio in Q1 2026, its #70 holding.
  • SNS Financial Group first reported a position in Eli Lilly in Q2 2015 and has held it in 26 quarters since.
  • SNS Financial Group's Eli Lilly position peaked at $2.33M in Q4 2021.
  • 4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on SNS Financial Group's 13F filing for Q1 2026, filed 14 Apr 2026.